Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Different γδ T cell types have unique roles in causing alopecia areata.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

A new mouse model effectively mimics vitiligo for research and drug testing.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Autoimmune reactions may cause both alopecia areata and HAM.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Immune system issues may contribute to female pattern hair loss.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.